TNXT - ETF AI Analysis
Top Page
T. Rowe Price Innovation Leaders ETF (TNXT)
TNXT, the T. Rowe Price Innovation Leaders ETF, appears to be a solid, innovation-focused fund supported by major tech leaders with strong financial performance and growth in areas like AI, cloud, and data centers. Heavy exposure to companies such as Alphabet, Microsoft, Apple, and Nvidia boosts the fund’s quality through robust profitability and long-term growth strategies, while some holdings face risks from high valuations, mixed technical signals, and cash flow or leverage concerns. The main risk factor is the fund’s concentration in large, premium-valued technology and AI-related names, which could increase volatility if growth expectations are not met.
TNXT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 18.69M
- Region
- Developed Markets
- Expense Ratio
- 0.49%
- Beta
- 1.34
- Issuer
- T. Rowe Price
- Inception Date
- Jan 28, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
TNXT Summary
TNXT, the T. Rowe Price Innovation Leaders ETF, is an actively managed fund that focuses on companies leading the way in new technologies and business ideas, mainly in the U.S. It doesn’t track a fixed index, but instead looks for innovators across the whole stock market, with a big tilt toward technology and healthcare. Well-known holdings include Nvidia and Apple. Investors might consider TNXT if they want growth potential from companies shaping the future economy. However, because it leans heavily on fast-growing, innovation-focused stocks, its price can be more volatile and may rise or fall more than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because this fund is actively managed and focuses on specialized innovation leaders, which typically costs more to run.
What would affect this ETF?
This ETF is heavily invested in innovative technology and healthcare companies like Nvidia, Apple, and Eli Lilly, so it could benefit if new breakthroughs in areas such as artificial intelligence, cloud computing, and medical treatments continue and if interest rates stabilize or fall, which often supports growth-focused stocks. On the other hand, it could be hurt by higher interest rates, stricter tech or healthcare regulations, slower economic growth in developed markets, or a shift in investor preference away from fast-growing companies toward more defensive or value-oriented sectors.
TNXT Top 10 Holdings
TNXT is essentially riding the Big Tech and chip wave, with Nvidia, AMD, and Broadcom forming a powerful but volatile semiconductor core. AMD has been a standout, rising strongly this year, while Nvidia’s momentum has cooled recently and Broadcom has been lagging, slightly tugging on returns. Apple and Microsoft have been steady engines of growth, helping smooth out the bumps, and Eli Lilly adds a fast-growing healthcare twist. With most heavyweights in U.S. tech and healthcare, the fund is clearly concentrated in innovative, developed-market leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NVDA | Nvidia | 7.90% | $1.47M | $4.98T | -6.97% | 76Outperform |
 AAPL | Apple | 5.84% | $1.09M | $4.84T | 27.40% | 79Outperform |
 MSFT | Microsoft | 4.14% | $770.82K | $3.87T | 5.67% | 79Outperform |
 AMZN | Amazon | 3.44% | $640.85K | $2.71T | 4.00% | 71Outperform |
 AVGO | Broadcom | 2.59% | $481.73K | $1.59T | -18.79% | 76Outperform |
 META | Meta Platforms | 2.37% | $441.70K | $1.59T | -4.85% | 76Outperform |
 AMD | Advanced Micro Devices | 2.26% | $421.09K | $789.95B | 57.77% | 73Outperform |
 LLY | Eli Lilly & Co | 2.19% | $407.78K | $1.33T | 47.41% | 72Outperform |
 V | Visa | 2.02% | $376.15K | $805.38B | 24.28% | 70Outperform |
 TSLA | Tesla | 1.85% | $343.65K | $1.58T | -25.62% | 73Outperform |
TNXT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TNXT, the sentiment is Positive. The current price of 26.67 is below the 20-day moving average (MA) of 28.38, below the 50-day MA of 28.53, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.18 indicates Positive momentum. The RSI at 47.43 is Neutral, neither overbought nor oversold. The STOCH value of 24.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TNXT.
TNXT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| TNXT | $26.67 | $31.00(16.24% Upside) | $18.69M | 0.49% | 69Neutral |
 SEQ | $53.68 | $66.42(23.73% Upside) | $6.77B | 0.99% | 69Neutral |
 GDIV | $18.26 | $21.99(20.42% Upside) | $237.89M | 0.50% | 73Outperform |
 KNO | $61.55 | $82.14(33.46% Upside) | $43.06M | 0.75% | 69Neutral |
 RW | $25.30 | $29.16(15.24% Upside) | $16.83M | 0.95% | 63Neutral |
 HDMV | $38.36 | $41.30(7.67% Upside) | $15.14M | 0.80% | 61Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TNXT | T. Rowe Price Innovation Leaders ETF | 26.67 | 1.82 | 7.32% | |
| SEQ | Sequoia ETF | 53.68 | 1.44 | 2.76% | |
| GDIV | Harbor Dividend Growth Leaders ETF | 18.26 | 2.31 | 14.52% | |
| KNO | AXS Knowledge Leaders ETF | 61.55 | 11.56 | 23.13% | |
| RW | Rainwater Equity ETF | 25.30 | 0.11 | 0.44% | |
| HDMV | First Trust Horizon Managed Volatility Developed Intl ETF | 38.36 | 4.95 | 14.81% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.